Latest News for: receptor
Edit
Scientists design artificial pain receptor that senses pain intensity and self-heals
Phys Dot Org 18 Jan 2026
The quantized conductance (QC) phenomenon in memristors, where electricity flows through a material in discrete steps rather than a smooth stream, allowed the pain receptor to go beyond simply turning on and off in response to a stimulus.
Edit
Exploring mutations that spontaneously switch on a key brain cell receptor
Phys Dot Org 16 Jan 2026
....
Edit
Actin ‘waves’ help T cells reuse key receptors: IISc study
The Times of India 16 Jan 2026
This inward movement was thought to prepare the receptors for endocytosis, allowing the T cell to disengage from the APC.
Edit
Scientists watch cell receptors respond in real time as drugs bind
Phys Dot Org 15 Jan 2026
... receptors in living cells actually respond to activating substances.
Edit
Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression. (Nippon Chemiphar Co Ltd)
Public Technologies 15 Jan 2026
Edit
Uncovering a hidden mechanism in Met receptor activation
Phys Dot Org 14 Jan 2026
Researchers at the Nano Life Science Institute (WPI-NanoLSI), ...
Edit
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 ...
Nasdaq Globe Newswire 14 Jan 2026
Antidepressive effects and enhanced wakefulness were ...
Edit
Korea University Researchers Revive an Abandoned Depression Drug Target Using Structurally Novel NK1 Receptor Inhibitors
PR Newswire 14 Jan 2026
Structurally novel neurokinin-1 receptor inhibitors reduce depressive-like behavior and brain inflammation in mice ... Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitorsJournal.
Edit
CNT-9982, an orexin receptor 2 agonist, enhances wakefulness in marmosets, and in the Wistar Kyoto rat model of major depressive disorder, normalizes the arousal state phenotype and alleviates behavioral despair (743a9b) (Centessa Pharmaceuticals plc)
Public Technologies 14 Jan 2026
Edit
Jalen Coker se consolida como receptor confiable para Bryce Young en Carolina
Boston Herald 13 Jan 2026
Edit
Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV)
Pharmiweb 12 Jan 2026
Edit
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
PR Newswire 12 Jan 2026
... (GIP) receptors ... The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management ... Semaglutide is a GLP-1 receptor agonist that has been approved by the U.S.
- 1
- 2
- Next page »
